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Fibromyalgia (FM) is a syndrome primarily characterised by chronic, widespread musculo-
skeletal pain. In the aetiology of this syndrome a crucial role is played by complex interac-
tions among biological, genetic, psychological, and socio-cultural factors. Recently,
researchers have started to explore emotional functioning in FM, with their attention focused
on alexithymia, a personality construct that affects the regulation of a person’s own emo-
tions. On the other hand, the detection and experience of emotional signals from other peo-
ple have only been sparsely investigated in FM syndrome and no studies have investigated
the ability to represent other people’s mental states (i.e. Theory of Mind, ToM) in these pa-
tients. Here we present the first study investigating a large set of social-cognitive abilities,
and the possible relationships between these abilities and the performance on executive-
function tasks, in a homogenous sample of patients with FM.
Methodology
Forty women with FM and forty-one healthy women matched for education and age were in-
volved in the study. Social cognition was assessed with a set of validated experimental
tasks. Measures of executive function were used to test the correlations between this di-
mension and the social-cognitive profile of patients with FM. Relationships between social-
cognitive abilities and demographic, clinical and psychological variables were
also investigated.
Principal Findings
Patients with FM have impairments both in the regulation of their own affect and in the rec-
ognition of other’s emotions, as well as in representing other people’s mental states. No
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significant correlations were found between social cognition tasks and the subcomponents
of the executive function that were analysed.
Conclusions
The results show the presence of several impairments in social cognition skills in patients
with FM, which are largely independent of both executive function deficits and symptoms of
psychological distress. The impairments reported highlight the importance of adequately
assessing ToM and emotional functioning in clinical practice.
Introduction
Fibromyalgia (FM) is a syndrome primarily characterised by chronic, widespread musculoskel-
etal pain [1–2]. Its prevalence is estimated to be 3–6% of the world population [3], and it occurs
predominantly in women, with a female to male ratio of 10:1 [4–6]. FM symptoms are not re-
stricted to pain, but often include a heterogeneous group of other conditions, such as hyperal-
gesia and/or allodynia, physical and mental fatigue, disrupted or non-restorative sleep,
headache, irritable bowel, psychiatric disorders, cognitive impairment, and other functional
complaints [1, 7].
The aetiology of this syndrome is not completely understood, but a crucial role seems to be
played by complex interactions among biological, genetic, psychological, and socio-cultural
factors, such as medical illness, neuroendocrine disturbances, stress, and psychiatric disorders.
In particular, high levels of stress and psychiatric symptoms may negatively influence the per-
ception of disease severity, functional ability, and the threshold and tolerance for pain [8–11].
Some authors have indeed suggested that the development of FM might stem from stress-
induced disruption of the hypothalamic-pituitary-adrenal (HPA) axis [12]. Exposure to pro-
longed stressful conditions can alter the function of the HPA axis, with a consequent increase
in the production of corticotropin-releasing factor and potentially amplified pain perception.
For this reason, FM is often defined as a central sensitisation syndrome, caused by increased
sensitivity of the central nervous system to pain signals [13].
Among psychological factors, the high prevalence of depression (20–80%) and anxiety dis-
orders (13–64%) has been widely reported [14–15]. Only recently, researchers have also started
to explore emotional functioning in FM syndrome, with their attention focused on alexithymia,
a multifaceted personality construct that affects the regulation of a person’s own emotions [16–
20]. Alexithymia is characterised by difficulty in identifying and describing subjective feelings,
difficulty in distinguishing between feelings and bodily sensations of emotional arousal, re-
stricted imagination processes, and a stimulus-bound, externally oriented cognitive style [21–
22]. Most of these studies have reported high levels of alexithymia in patients with FM, suggest-
ing the presence of a deficit in emotional self-awareness.
On the other hand, the detection and experience of emotional signals from other people
have only been sparsely investigated in FM syndrome. A link between alexithymic traits and
deficits in the processing of other people’s emotions has been highlighted in both healthy indi-
viduals and specific clinical populations, e.g. affective disorders, eating disorders, borderline
and psychopathic personality disorders, schizophrenia, somatoform disorders [22–26]. To the
best of our knowledge, only one study to date has examined the ability to identify other peo-
ple’s emotions in FM syndrome [27]. The results of this study highlighted the fact that patients
with FM had reduced performance in a face-recognition task, with a higher percentage of
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misclassifications of emotional expressions compared with healthy controls. In addition, pain
intensity, alexithymia, depression, and anxiety were inversely related to recognition perfor-
mance, while psychiatric co-morbidity and medication had no impact on performance.
The ability to decipher information about the intentions and affective states of social part-
ners is crucial for the implementation of appropriate behaviour during social interactions. This
complex process is part of the so-called social cognition domain, defined as the ability to con-
struct mental representations of the relations that exist between oneself and others and to flexi-
bly use these representations to function effectively in one’s social environment [28–29].
Examples of social cognition abilities are the capacity to represent other people’s intentions
and beliefs (i.e. Theory of Mind, ToM) [30–31], and the ability to share and recognise the emo-
tions and sensations of others [32–33].
From a neurological point of view, ToM and emotional processing abilities are associated
with overlapping but distinct brain networks [34–36]. Common areas of activation are the pre-
frontal cortex, the superior temporal sulcus, and the temporo-parietal junctions. These areas
form the basis for making inferences about mental states [37–41]. However, these areas are not
sufficient for the evaluation of one’s own and other’s emotions, and it is necessary to recruit the
additional involvement of emotional networks, in particular those of the amygdala [34, 36, 42–
43]. In fact, while the amygdala is not involved in ToM processes per se [44], its role is crucial
in processing basic and social emotions, related both to the self and to others [36, 45–48].
The social cognition domain includes a series of different abilities, which gradually evolve
throughout the lifetime. An open issue concerns the relationship between these capacities, par-
ticularly ToM processes, and the higher-level cognitive skills known as executive functions
(EF). Growing numbers of studies are trying to address this relationship in patients with differ-
ent psychiatric and neurological conditions [49–57].
EF refers to all of the skills that people use to control and coordinate their cognitive abilities
and behavior. These are essential for independent everyday functioning in life, and for the es-
tablishment of adaptive social relations [58–59]. In the last decade, evidence for the multiface-
ted nature of EF has replaced the idea of a unitary function [60–63]. Among the several
classifications that have been proposed to distinguish EF subcomponents, the model of Miyake
et al. [63] identified three separate types of operations: Updating, Shifting, and Inhibition.
Updating is related to working memory and requires monitoring and coding information as
well as replacing old non-relevant information with new relevant information. Shifting implies
the ability to shift attention between different sub-tasks or different elements of the same task.
Inhibition is concerned with the individual’s ability to withhold dominant, automatic or pre-
potent responses when they are inappropriate, and is considered to be a key component in
planning abilities. Fisk and Sharp [64] later added a fourth subcomponent, and revised the
model of Miyake and colleagues. The factor, called Access, refers to the processes involved in
verbal fluency tasks, which are believed to mediate access to representations in long-
term memory.
Currently, there are two opposing views about the relationship between ToM abilities and
EF. Some authors believe that ToM is a circumscribed cognitive process, independent of gener-
al intellectual functioning and other cognitive domains, included EF [65]. Basing their ideas on
theoretical and experimental data, others have suggested instead that lower-level perceptual
abilities (e.g. detection of gaze direction and voice recognition) that are required for an appro-
priate implementation of ToM skills, may be related to specific and circumscribed cognitive
domains, while higher-order ToM processes, involving interpreting and associating informa-
tion as well as hypothesising, would be the result of a more general ability regarding metarepre-
sentation and EF [66].
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The present study is based on both clinical evidence, which has highlighted high levels of
emotional distress (depression, anxiety, and in particular, alexithymia) in patients with FM,
and neuroimaging and neuropsychological data that has reported functional and structural
alterations in brain areas crucial for ToM and emotional processing abilities (i.e. the prefrontal
cortex and amygdala) in these patients [67–70], as well as cognitive deficits in the EF domain
[69–72]. On these bases, the present study aimed to address two main objectives. The first goal
was to evaluate the social-cognitive profile of patients with FM, and analyse ToM and emotion-
al processing abilities. In particular, four different areas of the social cognition domain were ex-
amined: (1) regulation of one’s own emotions; (2) empathic capacities; (3) recognition of
other’s emotions; (4) representation of other people’s affective mental states (i.e., affective
ToM). The second goal was to explore the possible relationships between the performance on
executive-function tasks and performance on social-cognition tasks in patients with FM. Fur-
thermore, relationships between social-cognitive abilities and demographic, clinical and psy-
chological variables were also investigated for explorative purposes.
Materials and Methods
Ethics Statement
The study was approved by the San Giovanni Battista University Hospital’s ethics committee
and was conducted in accordance with the Declaration of Helsinki. All the participants gave
their written informed consent to participate in the study.
Participants and procedure
Forty female participants with FM (51.75 ± 7.76 years of age) were consecutively recruited
from the Fibromyalgia Integrated Outpatient Unit (FIOU), a multidisciplinary unit based on
the collaboration between rheumatologists, psychologists, and psychiatrists at the San Gio-
vanni Battista University Hospital of Turin. All patients had a main diagnosis of fibromyalgia,
made by rheumatologists who are experts in the field. In addition, a psychiatric interview based
on DSM IV-TR axis II criteria (Diagnostic and Statistical Manual of Mental Disorders, 4th edi-
tion, Text Revision) [75] was performed by an expert psychiatrist, in order to exclude FM pa-
tients with personality disorders. Exclusion criteria were as follows: less than 18 years old, low
education level (<5 years), and the presence or history of a neurological or a severe psychiatric
disorder. Forty-one healthy women (51.83 ± 7.78 years of age) were recruited to the HC group.
Exclusion criteria for the HC group were the presence of rheumatic diseases or chronic pain, as
well as the presence or history of a neurological or psychiatric disorder.
Pain evaluation
As an index of pain intensity, the item “Pain” of the Italian version of the Fibromyalgia Impact
Questionnaire (FIQ) [76–77] was used to assess the average intensity of pain in the previous
week on a scale ranging between 0 and 10.
Psychological assessment
The presence of symptoms of depression and anxiety was assessed using the Italian version of
the Hospital Anxiety and Depression Scale (HADS) [78–79]. It consists of 14 items on a 0 to 3
range, and is divided into two subscales, one for depression (HADS-D) and one for anxiety
(HADS-A). Each subscale score ranges from 0 to 21 and a score of 8 (cut-off) or more suggests
a level of depression/anxiety symptoms that is clinically relevant [80].
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Neuropsychological assessment
Neuropsychological assessment was performed, using tests for short-term memory (Digit
Span-Forward—DS F) [81], learning (Rey auditory-verbal learning test—AVLT) [82], and at-
tention (Trail-making test—TMT—A-B) [83]. For the investigation of executive functions,
four different tests were used, specific for each one of the four subcomponents into which EF
has been divided according to the models of Miyake et al. [63] and Fisk and Sharp [64]. Specifi-
cally, the Digit Span-Backward (DS B) [81] was employed for evaluating the Updating compo-
nent, the TMT B [83] for Shifting, the Tower of London (ToL) [84–85] for Inhibition, and the
verbal fluency (FAS) [82, 86] for Access.
Social cognition assessment
Twenty-Item Toronto Alexithymia Scale (TAS-20). Alexithymia was assessed using the Ital-
ian version of the Toronto Alexithymia Scale (TAS-20) [87–88]. Subjects were asked to indicate
the extent to which they agreed or disagreed with each statement on a five-point Likert scale.
The results provide a TAS-20 total score, and three subscale scores that measure different as-
pects of alexithymia: difficulty identifying feelings (Factor 1), which measures the inability to
distinguish specific emotions and between emotions and the bodily sensations of emotional
arousal; difficulty describing feelings (Factor 2), which assesses the inability to verbalise one’s
emotions to other people; and externally-oriented thinking (Factor 3), which evaluates the ten-
dency of individuals to focus their attention externally and not on the inner emotional experi-
ence [88–89]. The TAS-20 cut-off scores are as follows:51 no alexithymia, 52–60 borderline
alexithymia,61 alexithymia. This scale has shown good internal consistency and test-retest
reliability, as well as convergent, discriminant and concurrent validity [22], and it is currently
one of the most utilised instruments in studies of alexithymia and emotion.
Empathy Quotient (EQ). The EQ is a validated self-report questionnaire, employed to as-
sess the capacity to empathise with another, i.e. to recognise another’s affective state and to re-
spond to this with an appropriate emotion [90–91]. The EQ comprises 60 items, broken down
into two types: 40 items assessing empathy and 20 filler/control items, included to distract the
participant from a relentless focus on empathy. For each empathy item, a person can score 2, 1,
or 0, so the EQ has a maximum score of 80 (higher scores indicate greater empathy). The EQ is
able to detect considerable individual, gender, and group differences, in both general-popula-
tion and clinical samples.
Ekman 60 Faces. The Italian version of this test was used to assess the recognition of facial
expressions pertaining to basic emotions [92]. The Ekman 60 Faces Test uses photographs of
the faces of 10 actors (six female and four male) selected from the Ekman and Friesen [93] se-
ries. Each actor displays one of the six basic emotions investigated (happiness, sadness, disgust,
fear, surprise, and anger). The subject is required to respond verbally, deciding which of the six
labels for basic emotions that are placed below each photograph can best describe the facial ex-
pression shown. The maximum test score (indicating best performance) is 60 for all six emo-
tions and 10 for each basic emotion.
Reading the Mind in the Eyes Test (RME). The RME was employed to assess the ability to
represent other people’s affective mental states [94]. In the test, the experimenter presents a set
of 36 photographs of the eye region of various human faces. Participants are required to choose
among four words that are printed on the page that the picture appears on, using the criterion
of which word best describes the mental state of the person depicted in the photograph. Partici-
pants have unlimited time to decide, and a glossary is provided. Participants have to put them-
selves into the mind of another person and recognise his or her complex mental state. In the
gender-recognition control task, participants are asked to judge the gender of the person in
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each of the 36 photographs. For both the experimental (mental state attribution) and control
(gender attribution) conditions, the maximum score indicating the best performance is 36.
Statistical analyses
All the statistical analyses were conducted using IBM SPSS Statistics, version 20.0. Normal dis-
tribution was assessed using indices of asymmetry and kurtosis. Non-parametric equivalent
tests were performed on data that violated this assumption. For normally distributed variables,
independent t-tests were used. In order to evaluate the possible relationships between variables,
Spearman or Pearson correlations were computed, as appropriate.
Results
Demographic, clinical and psychological data
Data on the demographic and psychological variables are presented in Table 1. The two groups
were matched for age and education.
For psychological assessment we used data from the HADS total score and the scores for
subscales HADS-A and HADS-D. The results showed significantly higher scores in patients
with FM both for the total score (p< 0.001) and for each of the two subscales evaluating anxiety
(p< 0.001) and depression (p< 0.001). According to the cut-off scores of the HADS, 67.5%
(27/40) of the patients with FM showed a clinically relevant level of both anxiety and depres-
sion, compared with 34% (14/41) for anxiety (Χ2(1) = 9.011, p< 0.001) and 19.5% (8/41) for
depression (Χ2(1) = 19.000, p< 0.001) in the HC group.
Concerning the clinical characteristics of the FM group, patients reported 6.47 (± 5.81) years
of duration of illness and a high rate of pain intensity (7 ± 2.55 to the item “Pain” of the FIQ).
Neuropsychological assessment
The comparisons between the neuropsychological scores of the two groups are shown in
Table 2. Patients with FM performed worse than the HC group on all the four tasks evaluating
EF (p values ranging from< 0.001–0.011). Furthermore, a poorer performance in the FM
group also emerged in the DS F (p = 0.005), in the AVLT-Delayed recall (p = 0.006) and in the
TMT B-A (p = 0.004). No statistically significant differences were found on the other
neuropsychological measures.
Table 1. Demographic, clinical and psychological characteristics of the FM and HC groups.
FM Patients (N = 40) Healthy Controls (N = 41) Test (df) p
Age, years Mean rank 41.29 40.72 Z = -0.109 0.913
Years of education Mean (SD) 11.50 (3.33) 12.76 (3.68) t(79) = -1.610 0.111
Duration of illness, years Mean (SD) 6.47 (5.81) - - -
FIQ-Pain Mean (SD) 7.00 (2.55) - - -
HADS Total Mean (SD) 19.63 (6.57) 11.12 (5.76) t(79) = 6.205 <0.001
n% (15) 33 (82.5%) 11 (26.8%) Χ2(1) = 25.289 <0.001
HADS D Mean (SD) 9.58 (3.78) 5.05 (3.13) t(79) = 5.874 <0.001
n% (8) 27 (67.5%) 8 (19.5%) Χ2(1) = 19.000 <0.001
HADS A Mean (SD) 9.73 (3.78) 5.85 (3.49) t(79) = 4.785 <0.001
n% (8) 27 (67.5%) 14 (34.1%) Χ2(1) = 9.011 0.003
FM = Fibromyalgia, df = Degrees of freedom, FIQ-Pain = item “Pain” of the Fibromyalgia Impact Questionnaire, HADS = Hospital Anxiety and Depression
Scale, HADS-A and HADS-D = Anxiety and Depression subscales of the Hospital Anxiety and Depression Scale, SD = Standard deviation.
doi:10.1371/journal.pone.0116542.t001
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In order to bring out the individual differences that could be flattened by group analyses,
the individual scores were analysed comparing for each test the number of subjects with im-
paired or borderline performance according to the age- and education-corrected scores (equiv-
alent score1). The results showed that a significantly higher number of patients with FM
compared with HC had a deficient performance in the DS F (short-term memory) and
B (working memory), and in the Delayed recall task of AVLT (episodic memory) (see Table 3).
Social cognition tasks
Data from social cognition tasks are reported in Table 4.
Regulation of own emotions. Concerning alexithymia, statistical analyses revealed the
presence of significant differences between FM and HC on the TAS-20 total score (p< 0.001),
and on the F1 (p< 0.001) and F2 subscales (p = 0.011); in all these comparisons patients with
Table 2. Neuropsychological tests scores. Mean (SD) or mean rank, t-test or Mann–Whitney U test are listed.
FM Patients (N = 40) Healthy Controls (N = 41) Test (df) p
DS F 4.93 (1.05) 5.61 (1.07) t(79) = -2.911 0.005
AVLT 46.95 (9.43) 50.73 (8.72) t(79) = -1.875 0.064
AVLT D 9.98 (2.90) 11.63 (2.39) t(79) = -2.818 0.006
TMT A 45.41 36.70 Z = -1.669 0.095
TMT B-A 48.58 33.61 Z = -2.863 0.004
Executive functions measures
FAS 38.45 (11.31) 45.73 (9.07) t(79) = -3.640 < 0.001
DS B 3.59 (0.94) 4.54 (1.08) t(78) = -4.299 < 0.001
ToL 26.10 (4.40) 28.78 (4.82) t(79) = -2.610 0.011
TMT B 48.86 33.33 Z = -2.972 0.003
FM = Fibromyalgia, df = Degrees of freedom, DS F = Digit Span Forward, AVLT = Rey auditory-verbal learning test, AVLT D = Rey auditory-verbal
learning test Delayed recall, TMT = Trail Making Test, FAS = verbal fluency, DS B = Digit Span Backward, ToL = Tower of London (total score—range
0–36—given by the sum of the time-based scores of the twelve configurations to solve; the higher the score the higher the performance), SD =
Standard deviation.
doi:10.1371/journal.pone.0116542.t002
Table 3. Number and percentage of patients with FM and healthy controls with impaired or borderline performance (E.S. = 0–1) at
neuropsychological measures.
FM Patients (N = 40) Healthy Controls (N = 41) Test (df) p
DS F 17 (42.5%) 9 (22%) Χ2(1) = 3.923 0.048
AVLT 5 (12.5%) 1 (2.4%) Χ2(1) = 2.988 0.084
AVLT D 5 (12.5%) 0 (0%) Χ2(1) = 5.462 0.019
TMT A 0 (0%) 0 (0%) - -
TMT B-A 1 (2.5%) 0 (0%) Χ2(1) = 1.038 0.308
Executive functions measures
FAS 2 (5%) 0 (0%) Χ2(1) = 2.102 0.147
DS B 18 (45%) 6 (14.6%) Χ2(1) = 8.954 0.003
ToL 2 (5%) 1 (2.4%) Χ2(1) = 0.372 0.542
TMT B 1 (2.5%) 0 (0%) Χ2(1) = 1.038 0.308
FM = Fibromyalgia, df = Degrees of freedom, DS F = Digit Span Forward, AVLT = Rey auditory-verbal learning test, AVLT D = Rey auditory-verbal
learning test Delayed recall, TMT = Trail Making Test, FAS = verbal fluency, DS B = Digit Span Backward, ToL = Tower of London.
doi:10.1371/journal.pone.0116542.t003
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FM scored higher than HC. According to the TAS-20 cut-off scores, 27.5% (11/40) of the pa-
tients with FM were alexithymic and 45% (18/40) were borderline, compared with 7% (3/41)
and 19.5% (8/41), respectively, in the HC group.
Empathic capacity. No significant difference between the two groups was found in the
EQ score.
Recognition of others emotions. Concerning the Ekman 60 Faces Test, independent t-tests
revealed the presence of significant differences between the two groups on total score (p =
0.010), and on two of the six emotions investigated by means of the test, i.e. anger (p = 0.049)
and disgust (p = 0.016). Once again, patients with FM showed significantly lower scores, indi-
cating a reduced ability to recognise other people’s emotions, especially anger and disgust.
Representation of other people’s affective mental states. No significant difference between
FM and HC was found in the control task for RME. In the experimental condition, patients with
FM evidenced a significantly lower performance on the mental states attribution task (p = 0.007).
Correlations
The second aim of this study was to investigate the possible relationships between social cogni-
tion tasks and EF measures in patients with FM. Moreover, we also evaluated the correlations
between social cognition tasks and demographic, clinical and psychological data. To do that,
we only considered the variables that showed a significant difference in the comparison be-
tween FM and HC, i.e. TAS-20 F1, F2, and total score; Ekman anger, disgust and total score;
and RME experimental task.
Correlations between social cognition measures and EF tasks are listed in Table 5. As
shown, no significant correlation was found, with the only exception of a low positive
Table 4. Theory of Mind and emotional functioning measures scores.
FM Patients (N = 40) Healthy Controls (N = 41) Test (df) p
Regulation of one’s own emotions (Alexithymia)
TAS-F1 21.78 (6.77) 14.24 (5.83) t(79) = 5.368 <0.001
TAS-F2 15.30 (4.72) 12.61 (4.52) t(79) = 2.619 0.011
TAS-F3 18.00 (3.44) 17.59 (4.66) t(73.641) = 0.456 0.649
TAS-20 Total 54.75 (9.93) 44.56 (10.09) t(79) = 4.579 <0.001
Empathic capacities
EQ 45.95 (9.00) 48.44 (8.54) t(79) = -1.277 0.205
Recognition of other’s emotions
Ekman Anger 7.98 (1.37) 8.61 (1.50) t(79) = -2.002 0.049
Ekman Sadness 7.55 (1.55) 8.00 (1.20) t(73.540) = -1.456 0.150
Ekman Fear 6.15 (2.53) 6.54 (2.64) t(79) = -0.673 0.503
Ekman Surprise 37.43 44.49 Z = -1.502 0.133
Ekman Disgust 34.89 46.96 Z = -2.401 0.016
Ekman Happiness 38.96 42.99 Z = -1.111 0.266
Ekman Total 48.78 (4.80) 51.41 (4.23) t(79) = -2.627 0.010
Representation of other people’s affective mental states (Theory of Mind)
RME Experimental 24.53 (3.81) 26.80 (3.55) t(79) = -2.787 0.007
RME Control 43.38 38.68 Z = -0.973 0.331
FM = Fibromyalgia, df = Degrees of freedom, TAS-20 = Twenty-item Toronto Alexithymia Scale, TAS-F1 = Difficult identifying feelings factor of Toronto
Alexithymia Scale, TAS-F2 = difficulty describing feelings factor of Toronto Alexithymia Scale, TAS-F3 = externally-oriented thinking factor of Toronto
Alexithymia Scale, EQ = Empathy Quotient, RME = Reading the Mind in the Eyes, SD = Standard deviation.
doi:10.1371/journal.pone.0116542.t004
Social Cognition in Fibromyalgia Syndrome
PLOSONE | DOI:10.1371/journal.pone.0116542 January 16, 2015 8 / 16
correlation between the Ekman total score and the DS B. In addition, we verified the possible
relationships between social cognition measures, EF tasks and duration of illness (DI) in FM
group and no significant correlation emerged (DI and FAS: r = -0.276, p: ns; DI and DS B:
r = -0.132, p: ns; DI and ToL: r = 0.196, p: ns; DI and TMT B: rs = 0.185, p: ns; DI and TAS-20
F1: r = 0.319, p: ns; DI and TAS-20 F2: r = 0.333, p: ns; DI and TAS-20 Total: r = 0.342, p: ns;
DI and Ekman Anger: r = 0.087, p: ns; DI and Ekman Disgust: rs = -0.175, p: ns; DI and Ekman
Total: r = -0.036, p: ns; DI and RME Experimental: r = -0.053, p: ns).
Regarding the relationship between social cognition measures and demographic, clinical and
psychological variables, no significant correlations were detected between age, HADS-A, HADS-
D, FIQ-pain, and the RME experimental or the Ekman anger, disgust and total score; a positive
correlation was only found between the RME experimental and the level of education (r = 0.359,
p = 0.023). However, significant correlations were detected between demographic, clinical and
psychological variables and the TAS-20 scores. In particular, positive correlations were found be-
tween the TAS-20 total score and the HADS-A (r = 0.334, p = 0.035), the HADS-D (r = 0.630, p
< 0.001), and the FIQ-pain (r = 0.518, p = 0.001). Likewise, positive correlations were found be-
tween the TAS-20 F1 and the HADS-A (r = 0.462, p = 0.003), the HADS-D (r = 0.476, p = 0.002)
and the FIQ-pain (r = 0.442, p = 0.004). Finally, the TAS-20 F2 was positively correlated only
with the HADS-D (r = 0.537, p< 0.001) and the FIQ-Pain (r = 0.344, p = 0.030).
Discussion
The present study aimed to address two main objectives. Firstly, we evaluated the social-
cognitive profile of patients with FM, investigating ToM and emotional processing abilities.
Secondly, we analysed the relationship between EF deficits and social cognition tasks in pa-
tients with FM. Correlations between demographic, clinical and psychological variables, and
measures of social cognition were also evaluated.
The results highlighted a significant difference between patients with FM and the HC group
in most of the social cognition tasks employed. In particular, the FM group showed significant-
ly higher levels of alexithymia, especially in the subscales “Difficulty in identifying feelings”
and “Difficulty describing feelings” of TAS-20, compared to the control sample. These data are
in line with most of the studies that have evaluated the prevalence of alexithymia in patients
with FM [16–20].
A similar significant difference was found for the experimental task of the RME, while no
significant difference was observed for the control task. Patients with FM experienced specific
difficulties in representing other people’s affective mental states that cannot be attributed to a
Table 5. Pearson or Spearman correlations in FM group between the four executive function measures and TAS-20, Ekman and RME.
FAS DS B ToL TMT B
TAS-F1 r = -0.206 p = 0.203 r = -0.077 p = 0.641 r = -0.200 p = 0.215 rs = 0.244 p = 0.129
TAS-F2 r = -0.078 p = 0.631 r = 0.198 p = 0.226 r = 0.165 p = 0.309 rs = -0.151 p = 0.351
TAS-20 Total r = -0.183 p = 0.258 r = 0.113 p = 0.495 r = 0.061 p = 0.708 rs = 0.019 p = 0.906
Ekman Anger r = -0.085 p = 0.600 r = 0.000 p = 1000 r = 0.184 p = 0.257 rs = 0.206 p = 0.203
Ekman Disgust rs = 0.224 p = 0.165 rs = 0.026 p = 0.876 rs = -0.031 p = 0.850 rs = -0.196 p = 0.225
Ekman Total r = 0.259 p = 0.106 r = 0.322 p = 0.046 r = -0.125 p = 0.443 rs = -0.311 p = 0.051
RME Experimental r = 0.299 p = 0.061 r = 0.232 p = 0.156 r = -0.112 p = 0.492 rs = -0.121 p = 0.457
FAS = verbal fluency, DS B = Digit Span Backward, ToL = Tower of London, TMT = Trail Making Test, TAS-20 = Twenty-item Toronto Alexithymia Scale,
TAS-F1 = Difficult identifying feelings factor of Toronto Alexithymia Scale, TAS-F2 = difficulty describing feelings factor of Toronto Alexithymia Scale, RME
= Reading the Mind in the Eyes.
doi:10.1371/journal.pone.0116542.t005
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basic sensory deficit. The Ekman 60 Faces Test results also showed the presence of significant
differences (lower performance of patients with FM) between the two groups both for the total
score and for two of the six emotions investigated by means of the test, i.e. anger and disgust;
no significant differences were found for other emotions. These data are in line with the only
study that has investigated the ability to recognise another’s facial emotions in patients with
FM [27]. As mentioned above, these authors showed that patients with FM had reduced perfor-
mance in the facial affect recognition task, with a higher percentage of misclassifications of
emotional expressions compared with the HC group.
The only social cognition task, in which no differences between the two groups were found,
was the EQ. In this case, the FM group didn’t report a lower capacity for empathy compared to
the control group.
Concerning the general cognitive profile, neuropsychological assessment revealed the pres-
ence of significant differences in most of the measures. In particular, the FM group displayed
significantly lower performance on the verbal fluency (FAS), the DS B and F, the AVLT-
Delayed recall, and the TMT B and B-A, compared to HC. These data are consistent with previ-
ous studies that have reported cognitive deficits in attention, memory, and EF domains in pa-
tients with FM [71–74]. In particular, Park et al. [71] found that patients with FM
demonstrated lower performance on measures of working memory, free recall, verbal fluency,
and verbal knowledge, but showed intact speed of processing, compared with age- and educa-
tion-matched controls. Significantly, patients with FM in that study performed no differently
from controls who were 20 years older on most cognitive tasks, with the exception of speed of
processing and vocabulary. Only self-reported pain on the Arthritis Impact Measurement Scales
predicted poor cognitive performance in the FM group. Measures of depression, anxiety, and
the McGill Pain Questionnaire scores were all unrelated to poor cognitive performance. Ver-
dejo-Garcia et al. [73] observed that in the Wisconsin Card Sorting Test, women with FM
showed poorer performance than healthy women on the number of categories and non-persev-
erative errors, but not on perseverative errors. Patients with FM also exhibited an altered learn-
ing curve in the original Iowa Gambling Task (IGT) (where reward is immediate and
punishment is delayed), suggesting compromised emotion-based decision-making. This was
not the case in the variant IGT (where punishment is immediate but reward is delayed), sug-
gesting hypersensitivity to reward. Self-reported pain intensity and pain interference were sig-
nificantly associated with task performance. In contrast, cognitive performance was not
associated with measures of negative mood (i.e. affective distress) or duration of pharmacologi-
cal treatment, and was very mildly associated with personality characteristics [73].
Finally, from a psychological standpoint, our group of patients with FM presented with sig-
nificantly higher levels of depressive and anxiety symptoms (67.5% in both cases) compared
with the HC group. These results corroborate, once again, the high prevalence of psychological
distress reported in previous studies of patients with FM [14–15, 19].
To the best of our knowledge, this is the first study to investigate social-cognitive abilities in a
homogenous sample of patients with FM. The results show that patients with FM have impair-
ments both in the regulation of their own affect and in the recognition of other’s emotions, as
well as in representing other people’s affective mental states. There is evidence that appropriate
behaviour in social interactions is determined by the ability to decipher information about the
intentions and affective states of social partners. Thus, impairments in facial affect recognition
and difficulties in accurately inferring other people’s affective mental states may lead to substan-
tial difficulties in interpersonal contacts (e.g. interaction problems with family and friends, or
social isolation), which have been already reported in patients with FM [95]. Furthermore, poor
psychosocial functioning and unsatisfactory relationships might contribute to the genesis and
maintenance of chronic pain [96], intensifying the symptomatology in individuals with FM.
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From a neurological standpoint, the brain networks relevant for pain and emotional pro-
cessing partially overlap. The amygdala plays a crucial role in sharing emotional experiences
and in recognising emotions in oneself and others [34, 36]. In particular, this structure is in-
volved in the decoding of emotional expressions, and modulates the activity of the fusiform
gyrus, which constitutes the most prominent face-selective area of the brain. Neuroimaging
studies have indeed shown sensitivity of the amygdala to the kind and valence of facially ex-
pressed emotions [97–98]. The insular cortex may also be relevant in this context. It has been
reported, for instance, that impaired disgust recognition is associated with reduced insula activ-
ity [99]. In addition to their prominent role in emotional functioning, the amygdala and the
insula are integral parts of the neural network underlying pain. Specifically, both structures are
involved in transmitting the affective dimension of pain perception [100] and are altered in pa-
tients with FM [69, 101]. The hyperactivity of the pain network due to central nervous system
sensitisation, may lead to an increased demand on structures such as the amygdala and insula,
reducing the available resources for other functions such as emotional processing.
As far as the second goal of this study is concerned, we investigated whether EF measures in
the FM group were related to the different social cognition tasks that were used. In addition,
we also analysed the possible relationships between demographic, clinical and psychological
variables, and measures of social cognition. Concerning EF tasks, no correlations were found
between social cognition tasks and each of the four subcomponents of the EF domain that were
analysed. The only exception was represented by a low positive correlation between the Ekman
total score and the DS B. Regarding the demographic, clinical and psychological variables, cor-
relation analyses showed no relationship between Ekman total score, anger and disgust, RME
experimental, on the one hand, and anxiety, depression and pain intensity, on the other hand.
Positive correlations were only detected between the latter measures (anxiety, depression, and
pain) and the total score and scores for the F1 and F2 subscales of the TAS-20. This result is
consistent with previous studies that have investigated the presence of alexithymia in FM pa-
tients [18, 20, 102]. In particular, Steinweg et al. [102] found higher levels of alexithymia in FM
patients compared with either general medical or rheumatoid arthritis patients. However, they
also revealed that alexithymia was strongly associated with moderate-to-severe depression, but
no group differences were detected when mood disturbance was controlled for.
Taken together, as far as the first aim of this study is concerned, the results show the pres-
ence of several impairments in social cognition skills in patients with FM. As for the second
aim, i.e. to explore the possible relationships between the performance on executive-function
tasks and the performance on social-cognition tasks in patients with FM, we found that the lat-
ter are largely independent of both EF deficits and symptoms of psychological distress. The
only exception seems to be represented by alexithymia; in fact, psychological disorders, but not
EF deficits, seem to play a role in explaining the high levels of alexithymia found in the FM
sample. Concerning other measures of social cognition, no relationship was found with EF def-
icits or symptoms of psychological distress. In our sample, impairments in ToM and emotional
processing ability appeared to be independent of the EF domain.
This study also has some limitations. Firstly, even though we enrolled an adequate number
of patients with FM, our study is still limited by a relatively small sample size. Secondly, the
self-reported measures we used might have elicited a bias towards social desirability, masking
the real profile of some individuals. Thirdly, although in patients with FM there is evidence of
structural and functional alterations in brain areas crucial for ToM and emotional processing
abilities (i.e. the prefrontal cortex and the amygdala) [67–70], we didn’t directly measure the
activity in these brain structures. Future studies should include neuroimaging evaluations and
use performance-based instruments for the analysis of both empathic capacity and alexithymia,
in addition to traditional self-reported tests.
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In spite of these limitations, the findings reported in the present study represent the first
contribution towards understanding the complex social-cognitive profile of patients with FM.
The impairments reported in tasks that evaluate ToM and emotional processing abilities high-
light the importance of adequately assessing these abilities in clinical practice. In this way, it
could be possible for clinicians to plan better pharmacological and/or psychological treatment
based on each patient’s needs.
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